Trademark: 79297218
Word
REVIVAL
Status Date
Thursday, October 20, 2022
Filing Date
Monday, May 25, 2020
Abandoned Date
Tuesday, October 11, 2022
5 Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
42 Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others
The mark consists of the stylized word "REVIVAL" in blue with four curved bands over the letters "VIV" all in a gradient of turquoise, evoking a rainbow; the color white in the mark represents background or transparent areas only and is not claimed as a feature of the mark.
The color(s) blue and turquoise is/are claimed as a feature of the mark.
Nov 12, 2023
Final Decision Transaction Processed By Ib
Oct 20, 2023
Final Disposition Notice Sent To Ib
Oct 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 20, 2022
Abandonment Notice E-Mailed - Failure To Respond
Oct 20, 2022
Abandonment Notice Mailed - Failure To Respond
Oct 20, 2022
Abandonment - Failure To Respond Or Late Response
Apr 24, 2022
Notification Of Possible Opposition - Processed By Ib
Apr 7, 2022
Notification Of Final Refusal Emailed
Apr 7, 2022
Final Refusal E-Mailed
Apr 7, 2022
Final Refusal Written
Apr 6, 2022
Notification Of Possible Opposition Sent To Ib
Apr 6, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 10, 2022
Assigned To Examiner
May 27, 2021
Teas/Email Correspondence Entered
May 27, 2021
Correspondence Received In Law Office
May 27, 2021
Teas Response To Office Action Received
Dec 20, 2020
Refusal Processed By Ib
Nov 29, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 29, 2020
Refusal Processed By Mpu
Nov 11, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Nov 10, 2020
Non-Final Action Written
Nov 10, 2020
Application Filing Receipt Mailed
Nov 6, 2020
Assigned To Examiner
Nov 6, 2020
New Application Office Supplied Data Entered
Nov 5, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
